Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases

Published:2021-11-02 Issue: Volume: Page:
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

van Liere Elsa L. S. A.^ORCID,Bayoumy Ahmed B.,Mulder Chris J. J.,Warner Ben,Hayee Bu,Mateen Bilal A.,Nolan Jonathan D.,de Boer Nanne K. H.,Anderson Simon H. C.,Ansari Azhar R.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-021-07273-y.pdf

Reference39 articles.

1. Harbord M et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis: Part 2: current management. J Crohn’s Colitis. 2017;11:769–784.

2. Torres J et al. ECCO guidelines on therapeutics in Crohn’s disease: Medical treatment. J Crohns Colitis. 2020;14:4–22.

3. Camus M et al. Long-term outcome of patients with Crohn’s disease who respond to azathioprine. Clin Gastroenterol Hepatol. 2013;11:389–394.

4. Chatu S et al. The role of thiopurines in reducing the need for surgical resection in Crohn’s disease: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:23–34 (quiz 35).

5. Ramadas AV et al. Natural history of Crohn’s disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates. Gut. 2010;59:1200–1206.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Density functional theory analyses of an iron-doped nanocage for the adsorption of allopurinol drug towards the development of novel carriers;Computational and Theoretical Chemistry;2024-07

2. Optimizing thiopurine therapy in autoimmune hepatitis: A multicenter study on monitoring metabolite profiles and co-therapy with allopurinol;Hepatology;2024-06-27

3. Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials;Scandinavian Journal of Gastroenterology;2024-03-05

4. Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care;Indian Journal of Gastroenterology;2024-02

5. Clinical trial: Combination allopurinol‐thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study);Alimentary Pharmacology & Therapeutics;2023-12-14